|
Nycomed International Management GmbH - SWOT AnalysisPublished by: Datamonitor Published: Jun. 4, 2008 - 28 Pages Table of Contents
AbstractDatamonitor's Nycomed International Management GmbH - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.Nycomed is a privately owned European pharmaceutical company. The company’s capabilities include product sourcing, late-stage clinical trials, registration, pricing and reimbursement negotiation and product life-cycle management. The company is headquartered in Zurich, Switzerland and employs about 11,700 people. The company recorded revenues of E3,497.4 million (approximately $4,794 million) during the fiscal year ended December 2007, as compared to the revenues of E869.9 million (approximately $1,192.4 million) in 2006. The operating profit of the company was E353.8 million (approximately $484.9 million) during fiscal year 2007, as compared to an operating profit of E46 million ($63 million) in 2006. The net profit was E235.4 million (approximately $322.7 million) in fiscal year 2007, as against a net loss of E83.3 million (approximately $114.3 million) in 2006. Scope of the Report
Get Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||